Rb1 identified as predictive biomarker for new therapeutic strategy in some breast cancers

A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

Oncotelic Cancer Drug Joint Venture Sapu Nano Makes Inroads With Spau003

Oncotelic Therapeutics Inc. 's (OTCQB: OTLC) Sapu Nano joint venture is making progress with Sapu003, its intravenous Deciparticle formulation of everolimus, the powerful drug to fight cancer and ...
Medical News Today

Supplement mix helps reduce tumor aggressiveness in deadly brain cancer

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...